Gregory A Ahlberg's most recent trade in Abbott Laboratories was a trade of 2,820 Common shares without par value done at an average price of $99.8 . Disclosure was reported to the exchange on Feb. 28, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.77 per share. | 28 Feb 2023 | 2,820 | 39,737 (0%) | 0% | 99.8 | 281,351 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 100.70 per share. | 28 Feb 2023 | 1,317 | 38,420 (0%) | 0% | 100.7 | 132,622 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 37,483 | 37,483 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 9,504 | 42,557 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.76 per share. | 01 Oct 2022 | 221 | 33,053 (0%) | 0% | 96.8 | 21,384 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.41 per share. | 28 Feb 2022 | 2,561 | 34,373 (0%) | 0% | 122.4 | 313,492 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 118.15 per share. | 28 Feb 2022 | 1,099 | 33,274 (0%) | 0% | 118.2 | 129,847 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 54,280 | 54,280 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 11,647 | 36,934 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.94 per share. | 15 Nov 2021 | 30,935 | 46,855 (0%) | 0% | 59.9 | 1,854,244 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 30,935 | 15,468 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 15 Nov 2021 | 21,568 | 25,287 (0%) | 0% | 130 | 2,803,840 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.98 per share. | 15 Nov 2021 | 6,000 | 19,825 (0%) | 0% | 49.0 | 293,880 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 6,000 | 0 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 15 Nov 2021 | 3,905 | 15,920 (0%) | 0% | 130 | 507,650 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.13 per share. | 01 Oct 2021 | 220 | 13,825 (0%) | 0% | 118.1 | 25,989 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.58 per share. | 26 Feb 2021 | 2,282 | 15,097 (0%) | 0% | 121.6 | 277,446 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.61 per share. | 26 Feb 2021 | 1,052 | 14,045 (0%) | 0% | 120.6 | 126,882 | Common shares without par value |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 47,993 | 47,993 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | SENIOR VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 9,363 | 17,379 (0%) | 0% | 0 | Common shares without par value | |
Abbott Laboratories | Gregory A. Ahlberg | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 9,084 | 9,084 | - | - | Option (right to buy) | |
Abbott Laboratories | Gregory A. Ahlberg | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,490 | 8,016 (0%) | 0% | 0 | Common shares without par value |